Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shugeng Gao

Showing results (81-90 of 299) with videos related to

Pageof 30
Sort By:
Biomarker Research|April 19, 2022
Sintilimab for the treatment of non-small cell lung cancerLin Zhang, Weihao Lin, Fengwei Tan, et al.
Thoracic Cancer|April 4, 2024
Surgery challenges and postoperative complications of lung cancer after neoadjuvant immunotherapyGuangyu Bai, Xiaowei Chen, Yue Peng, et al.
Journal of Cardiothoracic Surgery|April 10, 2024
The characteristics and prognosis of different disease patterns of multiple primary lung cancers categorized according to the 8th edition lung cancer staging systemYalong Wang, Lingling Fang, Xiao Hu, et al.
Thoracic Cancer|March 9, 2018
Blind spot in lung cancer lymph node metastasis: Cross-lobe peripheral lymph node metastasis in early stage patientsNing Li, Fengwei Tan, Jiagen Li, et al.
Zhonghua Yi Xue Za Zhi|May 16, 2015
[Clinical analyses of surgical treatment for lung metastatic tumors]Liang Zhao, Longhai Yang, Baihua Zhang, et al.
Journal of Thoracic Disease|November 19, 2021
Comparison of surgical difficulty in patients with resectable non-small cell lung cancer under different neoadjuvant treatment modes: a retrospective cohort studyFan Zhang, Bin Qiu, Ying Ji, et al.
Translational Cancer Research|February 4, 2022
Identification of prognostic genes and tumor-infiltrating immune cells in the tumor microenvironment of esophageal squamous cell carcinoma and esophageal adenocarcinomaQilin Huai, Wei Guo, Liankui Han, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 1, 2008
Elevated expression of UBE2T in lung cancer tumors and cell linesJia Hao, Anjian Xu, Xiaolei Xie, et al.
Radiation Oncology (London, England)|December 11, 2013
Risk factors for locoregional recurrence in patients with resected N1 non-small cell lung cancer: a retrospective study to identify patterns of failure and implications for adjuvant radiotherapyChengcheng Fan, Shugeng Gao, Zhouguang Hui, et al.
Translational Lung Cancer Research|March 18, 2024
The presence of micropapillary and/or solid subtypes is an independent prognostic factor for patients undergoing curative resection for stage I lung adenocarcinoma with ground-glass opacityRunze Li, Zhifei Li, Zhenlin Yang, et al.
Pageof 30

Showing results (81-90 of 299) with videos related to

Sort By:
Pageof 30
Biomarker Research|April 19, 2022
Sintilimab for the treatment of non-small cell lung cancerLin Zhang, Weihao Lin, Fengwei Tan, et al.
Thoracic Cancer|April 4, 2024
Surgery challenges and postoperative complications of lung cancer after neoadjuvant immunotherapyGuangyu Bai, Xiaowei Chen, Yue Peng, et al.
Journal of Cardiothoracic Surgery|April 10, 2024
The characteristics and prognosis of different disease patterns of multiple primary lung cancers categorized according to the 8th edition lung cancer staging systemYalong Wang, Lingling Fang, Xiao Hu, et al.
Thoracic Cancer|March 9, 2018
Blind spot in lung cancer lymph node metastasis: Cross-lobe peripheral lymph node metastasis in early stage patientsNing Li, Fengwei Tan, Jiagen Li, et al.
Zhonghua Yi Xue Za Zhi|May 16, 2015
[Clinical analyses of surgical treatment for lung metastatic tumors]Liang Zhao, Longhai Yang, Baihua Zhang, et al.
Journal of Thoracic Disease|November 19, 2021
Comparison of surgical difficulty in patients with resectable non-small cell lung cancer under different neoadjuvant treatment modes: a retrospective cohort studyFan Zhang, Bin Qiu, Ying Ji, et al.
Translational Cancer Research|February 4, 2022
Identification of prognostic genes and tumor-infiltrating immune cells in the tumor microenvironment of esophageal squamous cell carcinoma and esophageal adenocarcinomaQilin Huai, Wei Guo, Liankui Han, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 1, 2008
Elevated expression of UBE2T in lung cancer tumors and cell linesJia Hao, Anjian Xu, Xiaolei Xie, et al.
Radiation Oncology (London, England)|December 11, 2013
Risk factors for locoregional recurrence in patients with resected N1 non-small cell lung cancer: a retrospective study to identify patterns of failure and implications for adjuvant radiotherapyChengcheng Fan, Shugeng Gao, Zhouguang Hui, et al.
Translational Lung Cancer Research|March 18, 2024
The presence of micropapillary and/or solid subtypes is an independent prognostic factor for patients undergoing curative resection for stage I lung adenocarcinoma with ground-glass opacityRunze Li, Zhifei Li, Zhenlin Yang, et al.
Pageof 30